Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel ...

AMSTERDAM, the Netherlands — For patients with unresectable intermediate-stage hepatocellular carcinoma, selective internal radioembolization and standard transarterial chemoembolization provide ...

Portal vein embolization (PVE) has become integral to preoperative preparation for major hepatic resection by redirecting portal blood flow to the future liver remnant (FLR). By selectively occluding ...

Algorithm for blood-based panel of methylated DNA and protein markers to detect early-stage hepatocellular carcinoma with high specificity. This is an ASCO Meeting Abstract from the 2020 ASCO Annual ...

Depending on the stage and severity of liver cancer, treatment options range from surgery and ablation to radiation, embolization, and drug therapies like immunotherapy and chemotherapy. For early ...

First global Phase III trial to show improved clinical outcome for systemic therapy in combination with transarterial chemoembolization (TACE) in this setting WILMINGTON, Del.--(BUSINESS WIRE)-- ...

Transarterial chemoembolization (TACE) is a type of treatment for liver cancer. It works by delivering chemotherapy drugs directly to the tumor and blocking its blood supply. Liver cancer occurs when ...

Approximately 25% of patients with colorectal cancer present with metastatic disease to the liver at diagnosis, and about 50% develop liver metastases at some point during the course of the disease.

Radiation for liver cancer plays a crucial role in treating the disease. It delivers precise, controlled radiation doses to the tumor site. While treatment options for liver cancer include surgery, ...

During the 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America in Chicago from Nov. 25 to 30, GE Healthcare announced the receipt of U.S. Food and Drug ...